Emerging Treatments for Persistent Hematospermia: What's on the Horizon?
Published: Oct 30, 2023
Persistent hematospermia can be concerning, but new treatments offer hope for those affected. This article highlights emerging therapies that are showing promise.
Contents
Finasteride: A Promising Option
Finasteride, a medication often used to treat prostate issues, shows potential for managing persistent hematospermia. In studies, it resolved symptoms in 67% of treated patients. This offers a non-invasive option for those not responding to traditional management strategies.
Laser Therapy: Precision Treatment
Endoscopic holmium laser therapy is gaining attention for its ability to address structural causes of hematospermia. This minimally invasive procedure can resolve symptoms by targeting obstructions or calculi in the ejaculatory ducts. It's a promising option for patients with persistent symptoms.

Continuous Antibiotic Infusion
For cases linked to infections, continuous antibiotic infusion via transrectal ultrasound-guided catheterization shows potential. This approach has achieved high success rates, offering a targeted treatment for refractory cases, even when no bacterial infection is documented.
Frequently Asked Questions
It's used to manage prostate issues and shows promise for hematospermia.
It targets structural causes like obstructions in the ejaculatory ducts.
It shows high success rates for infection-linked cases.
Some are emerging and may not be available everywhere.
The Future of Treatment
Emerging therapies offer new hope for managing persistent hematospermia effectively.
References
- Badawy AA, Abdelhafez AA, Abuzeid AM. Finasteride for treatment of refractory hemospermia: prospective placebo-controlled study. Int Urol Nephrol 2012; 44:371.
- Oh TH, Seo IY. Endoscopic Treatment for Persistent Hematospermia: A Novel Technique Using a Holmium Laser. Scand J Surg 2016; 105:174.
- Wang R, Chen L, Bai X, et al. Transrectal ultrasound-guided seminal vesicle catheterization with continuous antibiotic infusion for the treatment of refractory hematospermia. Exp Ther Med 2021; 21:32.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.
AI Doctor Visit Required
Appointments available 24/7
15-min consultation. No hidden costs.
AI Doctor Visit Required
For safety reasons we have been forced to end this consultation.
If you believe this is a medical emergency please call 911 or your local emergency services immediately.
If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.
Contact us
You can also email us at help@doctronic.ai
We aim to reply within 5-7 days
How likely are you to recommend Doctronic to friends or family?